Impact of other pretransplant characteristics
There were significant differences in the negative conversion rate of
HBsAb after transplantation between patients treated with and without
ATG (P=0.047), patients treated with and without corticosteroids
(P=0.009), and patients with and without GVHD (P<0.001).
However, there was no difference in the negative conversion rate of
HBsAb based on pretransplant characteristics, including patient age, sex
and human leukocyte antigen (HLA) compatibility
(P >0.05) (Table 2).